Expertise in
121
conditions

Dr. Yang D. Liu

Pediatrics
Kaiser Health Plan Family PHY 635
276 Hospital Pkwy, 
San Jose, CA 
Accepting New Patients
Expertise in
121
conditions
Kaiser Health Plan Family PHY 635
276 Hospital Pkwy, 
San Jose, CA 

Overview

Yang Liu is a Pediatrics provider practicing medicine in San Jose, California.

Dr. Liu is highly rated in 121 conditions, according to our data. His clinical expertise encompasses Cerebral Hypoxia, Gliomatosis Cerebri, Acute Pain, Endoscopy, and Lithotripsy.

He is actively involved in clinical research, co-authoring 20110 peer reviewed articles and participating in 8 clinical trials. Dr. Liu is currently accepting new patients.

Specialties

Pediatrics

Licenses

Pediatrics in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Kaiser Health Plan Family PHY 635
276 Hospital Pkwy, San Jose, CA 95119

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Decitabine-primed Tandem Targeting CD19 and CD20 Chimeric Antigen Receptor T Cells Treatment in Relapsed and/or Refractory Non-Hodgkin's Lymphoma Patients
Decitabine-primed Tandem Targeting CD19 and CD20 Chimeric Antigen Receptor T Cells Treatment in Relapsed and/or Refractory Non-Hodgkin's Lymphoma Patients
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
Intervention Type: Drug, Biological
Study Drugs: Decitabine, CD19/CD20-Positive CAR-T Cells
Study Phase: Phase 1/Phase 2
A Randomized, Single-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety and Efficacy of the Pan-immunotherapy in Subjects With Relapsed/Refractory Ovarian Cancer
A Randomized, Single-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety and Efficacy of the Pan-immunotherapy in Subjects With Relapsed/Refractory Ovarian Cancer
Enrollment Status: Completed
Publish Date: July 15, 2024
Intervention Type: Drug
Study Drugs: Manganese Chloride, Nab-paclitaxel, Platinum chemotherapy, Sintilimab
Study Phase: Phase 2
Anti-PD-1 Antibody SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma:an Open-label Phase II Trial
Anti-PD-1 Antibody SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma:an Open-label Phase II Trial
Enrollment Status: Unknown
Publish Date: April 01, 2019
Intervention Type: Drug
Study Drugs: SHR-1210 Anti-PD-1 Antibody, Decitabine
Study Phase: Phase 2
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Clinical Characteristics of the Chinese Patients With Lung Malignant Tumors Who Received Surgeries or Surgeries Plus Adjuvant Therapies
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Clinical Characteristics of the Chinese Patients With Lung Malignant Tumors Who Received Surgeries or Surgeries Plus Adjuvant Therapies
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of Lymph Skip Metastases and Prognoses of N2 Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Explore Clinical Characteristics of Lymph Skip Metastases and Prognoses of N2 Patients With Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Compare Prognoses of the Chinese Patients With N2 Non-small Cell Lung Cancer Who Received Adjuvant Chemotherapies and Perioperative Chemotherapies After Surgeries
A Multi-centre Real-world Non-interventional Observational Study to Compare Prognoses of the Chinese Patients With N2 Non-small Cell Lung Cancer Who Received Adjuvant Chemotherapies and Perioperative Chemotherapies After Surgeries
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness of Sublobar Dissection in the Chinese Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness of Sublobar Dissection in the Chinese Patients With Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness and Safety of Surgeries in the Chinese Early-stage Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness and Safety of Surgeries in the Chinese Early-stage Patients With Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: May 21, 2018
Intervention Type: Procedure
View 7 Less Clinical Trials

20043 Total Publications

Complete genome sequence of multidrug-resistant Salmonella enterica subsp. enterica serovar Enteritidis SD191 isolated from chicken liver, harboring a novel imipenem resistance mechanism.
Complete genome sequence of multidrug-resistant Salmonella enterica subsp. enterica serovar Enteritidis SD191 isolated from chicken liver, harboring a novel imipenem resistance mechanism.
Journal: Microbiology resource announcements
Published: September 08, 2026
Similar Doctors
Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Comprehensive Ophthalmology And Optometry

2452 Watson Ct, 
Palo Alto, CA 
 (22.7 miles away)
650-723-1143
Languages Spoken:
English
See accepted insurances

Scott Lambert is a Pediatrics provider practicing medicine in Palo Alto, California. Dr. Lambert is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Retinopathy of Prematurity, Lenz Microphthalmia Syndrome, Microphthalmia Syndromic 9, Cataract Removal, and Vitrectomy.

Expertise in
13
conditions
Dr. David K. Stevenson
Neonatology | Pediatrics
Expertise in
13
conditions
Dr. David K. Stevenson
Neonatology | Pediatrics
Referral may be required

Lucile Packard Children's Hospital Stanford

725 Welch Rd, 
Palo Alto, CA 
 (24.7 miles away)
650-497-8000
Languages Spoken:
English
See accepted insurances

David Stevenson is a Neonatologist and a Pediatrics provider practicing medicine in Palo Alto, California. Dr. Stevenson is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Transient Familial Hyperbilirubinemia, Newborn Jaundice, Bilirubin Encephalopathy, and Jaundice.

Expertise in
100
conditions
Dr. David A. Stevenson
Medical Genetics | Pediatrics
Expertise in
100
conditions
Dr. David A. Stevenson
Medical Genetics | Pediatrics
Referral may be required

Lpch Medical Group Div Of Lucile

725 Welch Rd, 
Palo Alto, CA 
 (24.7 miles away)
650-498-7200
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Stevenson is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Palo Alto, California. Dr. Stevenson is highly rated in 100 conditions, according to our data. His clinical expertise encompasses Neurofibromatosis Type 1 (NF1), Neurofibromatosis, RASopathies, Costello Syndrome, and Deep Brain Stimulation.

Frequently Asked Questions about Dr. Yang D. Liu

How do I make an appointment with Dr. Yang D. Liu?

You can book an appointment with Dr. Yang D. Liu by calling their office at 408-362-4740. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Yang D. Liu a top-rated expert for Cerebral Hypoxia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Yang D. Liu is classified as an Elite expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Yang D. Liu specialize in?

While Dr. Yang D. Liu is a Pediatrics, they have specific expertise in Cerebral Hypoxia, Endoscopy, and Gliomatosis Cerebri. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Yang D. Liu participate in research or clinical trials?

Yes. Dr. Yang D. Liu has published 20043 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Dr. Yang D. Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Yang D. Liu accept my insurance?

Dr. Yang D. Liu accepts most major insurance plans, including Aetna and Kaiser Permanente. We recommend calling the office directly at 408-362-4740 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Liu's expertise for a condition
ConditionClose
View All 45 Distinguished Conditions
View All 71 Advanced Conditions
View All 89 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile